Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 1;15(9):8717-8721.
doi: 10.21037/qims-2025-760. Epub 2025 Aug 12.

Late-onset familial cerebral cavernous malformation without a family history: a case description

Zhuangzhuang Zhang  1   2 , Weiping Sun  1   2 , Zhaoxia Wang  1   2 , Luhua Wei  1   2
Affiliations

Late-onset familial cerebral cavernous malformation without a family history: a case description

Zhuangzhuang Zhang et al. Quant Imaging Med Surg. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://qims.amegroups.com/article/view/10.21037/qims-2025-760/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Brain MRI showed multiple cerebral cavernous malformations. Brain MRI revealed a Zabramski Type II lesion (arrows) adjacent to the left lateral ventricle, characterized by a mixed signal on (A) T1-weighted and (B) T2-weighted FLAIR imaging, along with marked hypointensity on SWI (C). Additionally, multiple Zabramski Type IV lesions (arrowheads) were observed in the (A-C) bilateral frontal and parietal lobes, periventricular region, and (D-F) pons, characterized by significant hemosiderin deposition; this was not visible on (A,D) T1-weighted or (B,E) T2-weighted FLAIR imaging but was distinctly visible on (C,F) SWI. FLAIR, fluid-attenuated inversion recovery; MRI, magnetic resonance imaging; SWI, susceptibility-weighted imaging.
See this image and copyright information in PMC

References

    1. Smith ER. Cavernous Malformations of the Central Nervous System. N Engl J Med 2024;390:1022-8. 10.1056/NEJMra2305116 - DOI - PubMed
    1. Akers A, Al-Shahi Salman R, A Awad I, Dahlem K, Flemming K, Hart B, Kim H, Jusue-Torres I, Kondziolka D, Lee C, Morrison L, Rigamonti D, Rebeiz T, Tournier-Lasserve E, Waggoner D, Whitehead K. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 2017;80:665-80. 10.1093/neuros/nyx091 - DOI - PMC - PubMed
    1. Zabramski JM, Wascher TM, Spetzler RF, Johnson B, Golfinos J, Drayer BP, Brown B, Rigamonti D, Brown G. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994;80:422-32. 10.3171/jns.1994.80.3.0422 - DOI - PubMed
    1. Flemming KD, Lanzino G. Cerebral Cavernous Malformation: What a Practicing Clinician Should Know. Mayo Clin Proc 2020;95:2005-20. 10.1016/j.mayocp.2019.11.005 - DOI - PubMed
    1. Labauge P, Laberge S, Brunereau L, Levy C, Tournier-Lasserve E. Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Société Française de Neurochirurgie. Lancet 1998;352:1892-7. 10.1016/s0140-6736(98)03011-6 - DOI - PubMed

LinkOut - more resources